Skip to content
Matteo Lambertini, MD PhD· @matteolambe · X·· 1 day agoScore70

#BREASTCANCER

Body · original

Oral abstract #BreastCancer session at #ESMO26: updated 15-y results from @NSABPFoundation NSABP B42 trial on extended #letrozole in post menopausal women with HR+ disease
@OncoAlert @myESMO

609 views · 17 likes · 11 reposts · 0 replies

Source: Matteo Lambertini, MD PhD · x.com

CBACBA Frontier Insights (CFI)Chinese Biopharmaceutical Association (CBA)www.cba-usa.org